Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma
Summary. Background: Hepatocellular carcinoma (HCC) is an increasing problem worldwide. Determining a prognosis is important for the management of HCC. Aim: We aimed to investigate the impact of interleukin (IL)-29, galectin-3, leptin, fibronectin and protease-activated receptor-1 on the prognosis a...
Gespeichert in:
| Datum: | 2023 |
|---|---|
| Hauptverfasser: | Çavuş, B., Akyuz, F., İliaz, R., Akyuz, U., Duranyıldız, D., Serilmez, M., Tekin, D., Evirgen, S., Karaca, Ç., Demir, K., Beşışık, F., Kaymakoğlu, S. |
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
PH Akademperiodyka
2023
|
| Schlagworte: | |
| Online Zugang: | https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-14 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Experimental Oncology |
Institution
Experimental OncologyÄhnliche Einträge
-
Molecular phenotype of high-grade endometrioid carcinoma of the endometrium
von: Buchynska, L.G., et al.
Veröffentlicht: (2023) -
Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma
von: M. S. Chesnokov, et al.
Veröffentlicht: (2016) -
Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma
von: Chesnokov, M.S., et al.
Veröffentlicht: (2016) -
Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
von: Kravets, O.V., et al.
Veröffentlicht: (2023) -
Diagnosis of fibrolamellar hepatocellular carcinoma
von: L. M. Zakhartseva, et al.
Veröffentlicht: (2017)